T. Rowe Price Investment Management
ELV icon

T. Rowe Price Investment Management’s Elevance Health ELV Stock Holding History

T. Rowe Price Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
+4,012
New +$1.49M ﹤0.01% 703
2025
Q4 		– Sell
-1,508
Closed -$488K – 917
2025
Q3 		$488K Sell
1,508
-2,080
-58% -$647K ﹤0.01% 652
2025
Q2 		$1.4M Buy
3,588
+1,267
+55% +$510K ﹤0.01% 614
2025
Q1 		$1.01M Buy
2,321
+983
+73% +$395K ﹤0.01% 615
2024
Q4 		$494K Sell
1,338
-30,321
-96% -$12.7M ﹤0.01% 617
2024
Q3 		$16.5M Buy
31,659
+10,448
+49% +$5.58M 0.01% 534
2024
Q2 		$11.5M Buy
21,211
+5,114
+32% +$2.7M 0.01% 541
2024
Q1 		$8.35M Buy
16,097
+7,048
+78% +$3.51M 0.01% 545
2023
Q4 		$4.27M Buy
9,049
+5,688
+169% +$2.63M ﹤0.01% 531
2023
Q3 		$1.46M Buy
3,361
+2,646
+370% +$1.2M ﹤0.01% 550
2023
Q2 		$318K Buy
+715
New +$330K ﹤0.01% 553

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management's ELV Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 4,012 shares worth $1.55M. The stake represents ﹤0.01% of the portfolio and ranks #703 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in ELV as recently as Q3 2025.

T. Rowe Price Investment Management first reported a position in ELV in Q2 2023 and has held it in 11 quarters since. The position peaked at $16.5M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • T. Rowe Price Investment Management held 4,012 shares of Elevance Health worth $1.55M as of Q2 2026.
  • Elevance Health was a new T. Rowe Price Investment Management position in Q2 2026.
  • Elevance Health made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #703 holding.
  • T. Rowe Price Investment Management first reported a position in Elevance Health in Q2 2023 and has held it in 11 quarters since.
  • T. Rowe Price Investment Management's Elevance Health position peaked at $16.5M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.